Founder and Chief Executive Officer Revitalist Lifestyle and Wellness
Consumer and professional interest in psychedelic therapies to treat PTSD, addiction, major depression, and other behavioral health disorders has been rapidly growing. Organizations offering ketamine or esketamine, such as Revitalist Lifestyle and Wellness, are opening across the country, and promising research on psilocybin, MDMA, DMT, and other psychedelics may lead to FDA approval in the years ahead. At this year’s Retreat, hear from Revitalist founder and CEO Kathryn Walker as she shares not only the exciting opportunities to improve treatment outcomes using these therapies, but also significant growth potential for this new service area for behavioral healthcare providers—Revitalist aims to have 120 clinics nationwide by the end of 2023.